US1405011073 - Common Stock

Taking everything into account, **CSWC** scores **5** out of 10 in our fundamental rating. **CSWC** was compared to 213 industry peers in the **Capital Markets** industry. **CSWC** has only an average score on both its financial health and profitability. **CSWC** has a correct valuation and a medium growth rate.

In the past year **CSWC** has reported a negative cash flow from operations.

With a decent **Return On Invested Capital** value of **5.64%**, **CSWC** is doing good in the industry, outperforming **66.67%** of the companies in the same industry.

Measured over the past 3 years, the **Average Return On Invested Capital** for **CSWC** is below the industry average of **7.99%**.

The 3 year average ROIC (**4.51%**) for **CSWC** is below the current ROIC(**5.64%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.36% | ||

ROE | 11.03% | ||

ROIC | 5.64% |

ROA(3y)4.13%

ROA(5y)3.09%

ROE(3y)8.94%

ROE(5y)6.74%

ROIC(3y)4.51%

ROIC(5y)4.26%

Looking at the **Profit Margin**, with a value of **46.81%**, **CSWC** belongs to the top of the industry, outperforming **84.29%** of the companies in the same industry.

In the last couple of years the **Profit Margin** of **CSWC** has declined.

The **Operating Margin** of **CSWC** (**62.28%**) is better than **94.76%** of its industry peers.

With a decent **Gross Margin** value of **75.81%**, **CSWC** is doing good in the industry, outperforming **75.71%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 62.28% | ||

PM (TTM) | 46.81% | ||

GM | 75.81% |

OM growth 3Y7.54%

OM growth 5Y5.44%

PM growth 3Y-14.44%

PM growth 5Y-6%

GM growth 3Y1.01%

GM growth 5Y-0.18%

The number of shares outstanding for **CSWC** has been increased compared to 5 years ago.

Compared to 1 year ago, **CSWC** has an improved debt to assets ratio.

Based on the Altman-Z score of **1.24**, we must say that **CSWC** is in the distress zone and has some risk of bankruptcy.

The **Altman-Z score** of **CSWC** (**1.24**) is comparable to the rest of the industry.

A Debt/Equity ratio of **1.02** is on the high side and indicates that **CSWC** has dependencies on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.02 | ||

Debt/FCF | N/A | ||

Altman-Z | 1.24 |

ROIC/WACCN/A

WACCN/A

A Current Ratio of **9.76** indicates that **CSWC** has no problem at all paying its short term obligations.

Looking at the **Quick ratio**, with a value of **9.76**, **CSWC** belongs to the top of the industry, outperforming **94.76%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 9.76 | ||

Quick Ratio | 9.76 |

The **Earnings Per Share** has grown by an nice **18.42%** over the past year.

Looking at the last year, **CSWC** shows a very strong growth in **Revenue**. The Revenue has grown by **49.32%**.

The **Revenue** has been growing by **27.97%** on average over the past years. This is a very strong growth!

EPS 1Y (TTM)18.42%

EPS 3Y17.37%

EPS 5Y13.71%

EPS Q2Q%1.54%

Revenue 1Y (TTM)49.32%

Revenue growth 3Y37.78%

Revenue growth 5Y27.97%

Sales Q2Q%40.85%

The **Earnings Per Share** is expected to decrease by **-0.02%** on average over the next years.

The **Revenue** is expected to grow by **10.20%** on average over the next years. This is quite good.

EPS Next Y0.17%

EPS Next 2Y-0.02%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year13.83%

Revenue Next 2Y10.2%

Revenue Next 3YN/A

Revenue Next 5YN/A

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

Based on the **Price/Earnings** ratio of **9.97**, the valuation of **CSWC** can be described as reasonable.

Based on the **Price/Earnings** ratio, **CSWC** is valued a bit cheaper than 73.33% of the companies in the same industry.

The **Price/Forward Earnings** ratio is **9.96**, which indicates a very decent valuation of **CSWC**.

66.19% of the companies in the same industry are more expensive than **CSWC**, based on the **Price/Forward Earnings** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 9.97 | ||

Fwd PE | 9.96 |

Based on the **Enterprise Value to EBITDA** ratio, **CSWC** is valued a bit cheaper than the industry average as 70.95% of the companies are valued more expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | 16.94 |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

The decent profitability rating of **CSWC** may justify a higher PE ratio.

PEG (NY)60.4

PEG (5Y)0.73

EPS Next 2Y-0.02%

EPS Next 3YN/A

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 8.39% |

The dividend of **CSWC** has a limited annual growth rate of **0.11%**.

The dividend of **CSWC** decreased recently.

Dividend Growth(5Y)0.11%

Div Incr Years1

Div Non Decr Years1

DP123.44%

EPS Next 2Y-0.02%

EPS Next 3YN/A

**CAPITAL SOUTHWEST CORP**

NASDAQ:CSWC (7/16/2024, 2:26:07 PM)

**26.93**

**-0.01 (-0.04%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap1.21B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 8.39% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 9.97 | ||

Fwd PE | 9.96 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)60.4

PEG (5Y)0.73

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.36% | ||

ROE | 11.03% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 62.28% | ||

PM (TTM) | 46.81% | ||

GM | 75.81% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.11

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.02 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 9.76 | ||

Quick Ratio | 9.76 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)18.42%

EPS 3Y17.37%

EPS 5Y

EPS Q2Q%

EPS Next Y0.17%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)49.32%

Revenue growth 3Y37.78%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y